January 23, 2026
1 min read

Abbott shares sag as global diagnostic, nutrition business sales declines drag on earnings

Abbott Laboratories saw its shares down 10% at the end of trading Thursday, Jan. 22, as the market digested weaknesses from its fourth-quarter and full-year earnings report. | Abbott Laboratories saw its shares down 10% at the end of trading Thursday, Jan. 22 as the market digested weaknesses from its fourth-quarter and full-year earnings report.

Leave a Reply

Your email address will not be published.

Previous Story

Planned Parenthood CEO won’t negotiate with ‘bullies’

Next Story

Abbott expects to return to ‘positive growth’ in nutrition in 2H26

Previous Story

Planned Parenthood CEO won’t negotiate with ‘bullies’

Next Story

Abbott expects to return to ‘positive growth’ in nutrition in 2H26

Latest from Blog

Go toTop